Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2025-12-25 @ 8:24 PM
NCT ID: NCT04598269
Description: None
Frequency Threshold: 5
Time Frame: Day 1 (after dosing) through Day 42
Study: NCT04598269
Study Brief: Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ATI-1777 ATI-1777 topical solution 2.0% w/w, twice daily 0 None 0 23 4 23 View
Vehicle Vehicle topical solution, twice daily 0 None 0 25 0 25 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Blood creatine phosphokinase increased SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 23.1 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 23.1 View